Vaccine booster reveals high level of risk, Swiss study shows
Farmers Forum staff
If there is a health risk when taking a COVID vaccine booster don’t you think we ought to know? Don’t you think it should at least be studied?
Well, it has. In fact there is more than one study. A recent study in Switzerland of 777 healthcare workers had astonishing results. One in 35 participants were found to have a vaccine-associated myocardial injury after receiving the Moderna vaccine booster. In other words, 2.8 per cent who took the Moderna vaccine booster were diagnosed with heart injury.
Between December 2021 and February 2022, scientists from the department of cardiology and cardiovascular research institute in Basel, Swizerland, tested the participants’ blood two to three days after receiving the COVID vaccine booster to check for changes in specific markers for heart damage. The study was internationally peer reviewed, was not conducted by anyone related to companies making the vaccines and was accepted in the open journal of Heart Failure, by the Heart Failure Association of the European Society of Cardiology. The median age of the participants was 37.
“If someone said to me you could have this vaccine – as I did – but by the way there’s a 2.8 per cent chance you’ll have a vaccine-associated myocardial injury, I would have run a mile,” said Dr. John Campbell, a retired English nursing instructor, who has followed the science on the vaccine with ongoing online analysis and who responded to the Swiss study in lay terms. “I am furious at not being fully informed about this and you should be too. We’ve been treated like mushrooms on this and it is completely unacceptable.”
He added that, “This is just off the scale risk, off the scale completely. The only way you would take this kind of risk in health care is if the alternative is certain death. You don’t just take this level of risk. This is madness what has happened here.”
More women than men had a negative vaccine reaction but there were no cardiac arrests or life threatening episodes in the next 30 days. However, the researchers looked specifically for reactions to the vaccine and when they found heart injuries, they told the participants not to exercise. The participants were followed by physicians until the symptoms disappeared.
The question for another study, Campbell says, should be: Did the vaccine lower the participants’ protection to heart damage or were the participants already prone to vaccine damage? The study concluded that vaccine-associated myocardial injury is more common than previously thought.
Campbell, who has almost three-million Youtube subscribers, notes that a similar study from Israel reveals higher levels of vaccine injury after a fourth dose of the Pfizer vaccine in healthy participants.
Even though both studies were available, Canada’s chief medical advisor Dr. Supriya Sharma recommended in September that “Individuals who are five years of age and older should receive one dose of the vaccine.”
Disturbingly, Sharma would have had access to six peer-reviewed papers presented to the U.S. Senate Committed on Health, Labour and Pensions that concluded that there is a higher incidence of myocarditis among males 16 to 24 after taking the Moderna vaccine. Also, six months before Sharma’s recommendation, U.S. Senator Rand Paul told the Senate Committee that he spoke to the president of Moderna who “readily acknowledged in private that, yes, there is an increased risk of myocarditis.”